For the right patient, gastric sleeve is not just one of many GLP-1 alternatives
The result is a body that burns fewer calories and sends stronger hunger signals
Arillotta D, Floresta G, Guirguis A, et al
Diabetes care 29 , 435449 (2006)
Providers can now offer their GLP-1 patients a free, structured support program for nutrition, side effects, muscle health, movement, mindset, and the lasting habits that can help keep weight off for good PRINCETON, NJ June, 24 2026 Noom, the leading behavior change company trusted by millions, today announced the launch of its free GLP-1 Companion program, now available at no cost to anyone taking a GLP-1 medication, regardless of provider
71.2 lbs on average) Retatrutide 9mg: 26.4% body weight reduction Tirzepatide/Zepbound (Phase 3 comparison, not head-to-head): ~20.9% Semaglutide/Wegovy (Phase 3 comparison, not head-to-head): ~14.9% Placebo: ~2.1% Note: These figures come from separate Phase 3 trials and are not direct head-to-head comparisons